Oxide Or Hydroxide Patents (Class 424/688)
  • Patent number: 10683613
    Abstract: Compositions suitable for use in the bleaching of pulps may include one or more particulate alkaline earth metal oxides or alkaline earth metal hydroxides or mixtures thereof, and one or more pitch control additives. The compositions may be suitable for use in a pulp preparation or a papermaking process. A method for the bleaching of pulps may include providing the composition.
    Type: Grant
    Filed: June 6, 2014
    Date of Patent: June 16, 2020
    Assignee: ImerTech SAS
    Inventor: Mikko Likitalo
  • Patent number: 10231976
    Abstract: Provided are methods and kits for administering progestogen as a glucocorticoid sensitizer to restore corticosteroid sensitivity or reverse the glucocorticoid insensitivity or enhance glucocorticoid sensitivity, in order to treat one or more glucocorticoid insensitivity related diseases or conditions. For example, these include methods for reversing the glucocorticoid insensitivity in a subject having no history of menstrual cycle-related exacerbation or allergy to self-hormones, particularly progesterone, such as premenstrual or perimenstrual deterioration in the symptoms, e.g., premenstrual worsening of atopic dermatitis or premenstrual exacerbations of asthma, and exhibiting relatively or totally refractory responses to glucocorticoid therapy, e.g., glucocorticoid resistance. The methods and kits provide for the administration of a sex hormone to the subject who is corticosteroid dependent or corticoid resistant or unresponsive or intolerant to corticosteroids.
    Type: Grant
    Filed: February 7, 2011
    Date of Patent: March 19, 2019
    Assignee: PRAIRIE PHARMACEUTICALS LLC
    Inventor: Tao Tom Du
  • Patent number: 10172360
    Abstract: Methods and apparatuses for the direct electrochemical generation of high concentration, stable aqueous solutions comprised of mixtures of free halogen species, N-halosulfamate compounds, N-halosulfonamide, and other compounds for biocidal applications is disclosed. Solutions containing the desired content of these species, with the desired concentration and pH value, is achieved through the electrolysis of aqueous brines containing mixtures of metal halide compounds, sulfamic acid, and other additives as desired. Controlling the relative compositions of the brines used to prepare the desired biocidal solutions, as well as the electrolysis conditions, can produce the biocidal solution with the desired composition and properties.
    Type: Grant
    Filed: December 9, 2015
    Date of Patent: January 8, 2019
    Assignee: Johnson Matthey Public Limited Company
    Inventor: Andrew K. Boal
  • Patent number: 9234103
    Abstract: The object of the present disclosure is to obtain a filler particle having stable insulation property, and a resin composition, grease, and a coating composition comprising the same, respectively. Filler particles comprising a composite zinc oxide expressed by the following chemical formula (1): ZnxMyO??(1) in the formula, M is Mg, Co, Li, K, Na, or Cu, and x+ny/2=1 when the valence of M is n.
    Type: Grant
    Filed: October 26, 2012
    Date of Patent: January 12, 2016
    Assignee: Sakai Chemical Industry Co., Ltd.
    Inventors: Satoru Sueda, Atsuki Terabe, Hiroyuki Izumikawa, Mitsuo Hashimoto
  • Patent number: 9051386
    Abstract: A method of treating inflammation by administering a therapeutically effective amount of a human immunosuppressant protein (HISP) to a subject is presented. The inventors have discovered a novel immunosuppressive protein purified from the supernatant of hNT cell culture. The immunosuppressant protein has a molecular weight of about 40-100 kDa, an isoelectric point of about 4.4, a net ionic charge and is capable of suppressing T-cell activation, T-cell proliferation and the production of IL-2. This protein can be used in treating inflammation, preventing graft rejection after transplantation, treating autoimmune diseases and suppressing allergic responses as well as other uses.
    Type: Grant
    Filed: March 20, 2014
    Date of Patent: June 9, 2015
    Assignee: University of South Florida
    Inventors: Paul R. Sanberg, Robert W. Engelman, William R. Gower
  • Publication number: 20150132351
    Abstract: Methods of using a polymeric composition are described for preventing or reducing the signs of aging. The polymeric composition can include a polymer matrix and one or a plurality of mineral filler(s), uniformly dispersed in the polymer matrix, having properties of absorption and/or emission in the far infrared region ranging from 2 ?m to 20 ?m.
    Type: Application
    Filed: May 21, 2013
    Publication date: May 14, 2015
    Inventors: Thomas Gonzaga Canova, Gabriel Gorescu, Tarcis Cordeiro Bastos
  • Publication number: 20150132387
    Abstract: The invention relates to the treatment of inflammatory bowel disease, also termed IBD, including ulcerative colitis and Crohn's disease. To this end, the invention proposes clinoptilolite having a particle size between 0.2 and 1 ?m for use in the treatment of inflammatory bowel disease, also termed IBD, in mammals and humans. In the case of such use, the clinoptilolite is preferably freed of heavy metals. In one variant, it is administered orally, optionally with pharmaceutically harmless carrier materials and/or diluents.
    Type: Application
    Filed: November 10, 2014
    Publication date: May 14, 2015
    Inventor: Gaston GLOCK
  • Patent number: 8980330
    Abstract: Provided is a method that enables a calcium silicate-based material to be produced more efficiently. The method of producing a calcium silicate-based material comprises: (1) a step of obtaining a reaction product by reacting raw materials containing a calcium component, a silicon component and an aluminum component in an aqueous medium; and (2) a step of forming calcium silicate by subjecting the reaction product to hydrothermal treatment.
    Type: Grant
    Filed: February 27, 2013
    Date of Patent: March 17, 2015
    Assignee: Tomita Pharmaceutical Co., Ltd.
    Inventors: Koh Konishi, Yuta Tsumura, Seiki Shinomiya, Masashi Konishi, Yukinori Konishi
  • Publication number: 20150004256
    Abstract: A method and an apparatus for disinfecting sewage sludge are disclosed, in which sewage sludge is loaded from a silo into an open container, the open container is transferred away from the loading site, a granular calcium oxide (CaO) is dispensed into the sludge, a diluted peracetic acid solution is dispensed into the sludge and the sludge is mixed in the open container by at least four horizontal mixing screws for about two hours.
    Type: Application
    Filed: February 1, 2013
    Publication date: January 1, 2015
    Inventor: Reima PYY
  • Publication number: 20140271786
    Abstract: Bioactive porous bone graft implants in various forms suitable for use in bone tissue regeneration and/or repair, as well as methods of use are provided. The implants are formed of bioactive glass and have an engineered porosity. The implants may be contained in polymer for enhanced clinical results and better handling.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 18, 2014
    Applicant: Prosidyan, Inc.
    Inventors: Charanpreet S. BAGGA, Steve B. Jung, Hyun W. Bae
  • Publication number: 20140271785
    Abstract: Bioactive porous bone graft implants in various forms suitable for bone tissue regeneration and/or repair, as well as methods of use, are provided. The implants are formed of bioactive glass and have an engineered porosity. The implants may take the form of a putty, foam, fibrous cluster, fibrous matrix, granular matrix, or combinations thereof and allow for enhanced clinical results as well as ease of handling.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 18, 2014
    Applicant: PROSIDYAN, INC.
    Inventors: Charanpreet S. BAGGA, Steve B. JUNG, Hyun W. BAE
  • Publication number: 20140255465
    Abstract: The present invention provides novel methods of making a non-corrosive base solution for use as an alkalinity increasing agent and/or antioxidant. The present invention further provides novel compositions and methods which can be used to provide relief from acidosis, acidemia, and disorders related to or complicated by acidosis or excessive free radical or other reactive oxygen species production in mammalian subjects.
    Type: Application
    Filed: March 9, 2014
    Publication date: September 11, 2014
    Applicant: COGNATE3 LLC
    Inventors: Suzannah Jane ROBERTS, Stephanie Jo BLACKWELL, Shannon Joe BROWN
  • Patent number: 8795718
    Abstract: The present invention utilizes a nano-coating of an oxide such as silica, a silicate or another effective oxide on a surface to accelerate blood clotting in mammalian animals. The hemostatic layer has a thickness that is effective for the hemostasis, yet can be made thin enough to result in a resorbable film which can either be applied to a biocompatible or resorbable device that can be used in surgical applications as well as in topical applications such as trauma.
    Type: Grant
    Filed: May 22, 2008
    Date of Patent: August 5, 2014
    Assignee: Honeywell International, Inc.
    Inventors: Robert L. Bedard, Steven A. Wilcher
  • Patent number: 8747912
    Abstract: A drug delivery system for the controlled release of a pharmaceutically-active compound by oral route comprises an intercalate of a layered double hydroxide having, before intercalation, layers of metal hydroxides, and having intercalated therein a pharmaceutically-active compound having at least one anionic group. A preferred layered double hydroxide is one that has layers which comprise [LiAl2(OH)6]+. The drug delivery system has use in the delivery of drugs such as 4-biphenylacetic acid, Diclofenac, Gemfibrozil, Ibuprofen, Naproxen, 2-Propylpentanoic acid and Tolfenamic acid.
    Type: Grant
    Filed: January 28, 2008
    Date of Patent: June 10, 2014
    Assignee: Isis Innovation Limited
    Inventor: Dermot Michael O'Hare
  • Patent number: 8709500
    Abstract: A drug delivery system for the controlled release of a pharmaceutically-active compound by oral route comprises an intercalate of a layered double hydroxide having, before intercalation, layers of metal hydroxides, and having intercalated therein a pharmaceutically-active compound having at least one anionic group. A preferred layered double hydroxide is one that has layers which comprise [LiAl2(OH)6]+. The drug delivery system has use in the delivery of drugs such as 4-biphenylacetic acid, Diclofenac, Gemfibrozil, Ibuprofen, Naproxen, 2-Propylpentanoic acid and Tolfenamic acid.
    Type: Grant
    Filed: June 23, 2010
    Date of Patent: April 29, 2014
    Assignee: Isis Innovation Limited
    Inventor: Dermot Michael O'Hare
  • Patent number: 8691144
    Abstract: The present invention relates to an air filtration system and a method for making a photocatalytic oxidation substrate by powder coating a photocatalyst onto a metal substrate.
    Type: Grant
    Filed: December 11, 2012
    Date of Patent: April 8, 2014
    Assignee: Garfield Industries, Inc.
    Inventors: Kirk Garfield, John Potter
  • Patent number: 8658188
    Abstract: Nanoparticulate material containing a matrix and embedded therein a radiopacifier are bioactive, show a high alkaline capacity and are radio-opaque. Compositions and formulations including such material are particularly useful in advanced dental applications, such as dental fillings and/or disinfection.
    Type: Grant
    Filed: August 17, 2010
    Date of Patent: February 25, 2014
    Assignees: Universitat Zurich
    Inventors: Wendelin Jan Stark, Dirk Mohn, Matthias Zehnder, Thomas Imfeld
  • Patent number: 8658193
    Abstract: Technologies are described herein for styptic compounds comprising a hemostatic or styptic agent suspended within a hydrophobic carrier medium. Example carrier mediums may include waxes, lipids, oils, or combinations thereof. The compound may be a semisolid at room temperature and soft enough to be easily dispensed and formed into or onto bleeding tissue of an animal or human. The hydrophobic qualities of the carrier medium can protect the styptic agent from absorbing moisture. The carrier medium can mechanically support positioning treatments adjacent to the bleeding tissue. The carrier medium can further serve to mechanically seal the tissue to aid in hemostasis while also protecting the tissue from debris and contamination. The carrier medium can aid in maintaining moisture within the tissue. Slurry-based manufacturing processes can support a substantially homogeneous dispersal of styptic agent throughout the carrier medium.
    Type: Grant
    Filed: June 8, 2012
    Date of Patent: February 25, 2014
    Inventor: Robert J. Greenwald
  • Patent number: 8652495
    Abstract: Disclosed are oral care compositions, for example dentifrice compositions, comprising an oral care composition comprising an orally acceptable vehicle, metal oxide particles having an average particle size of no greater than a dentin tubule and at least one amino acid capable of chelating the metal oxide. The composition may comprise a polymeric adherent material for adhering the metal oxide particles in the dentin tubule. The metal oxide particles have a median particle size of 5 microns or less, and may comprise zinc oxide.
    Type: Grant
    Filed: March 31, 2010
    Date of Patent: February 18, 2014
    Assignee: Colgate-Palmolive Company
    Inventors: Venda Porter, Andre Morgan, Michael Prencipe
  • Patent number: 8551533
    Abstract: An adjuvant composition is provided which comprises: (a) at least one water-soluble electrolyte; (b) at least one electrolyte-tolerant surfactant; (c) antifoam component which is at least one mixture selected from the group consisting of (1) at least one branched silicone resin (i), at least one silicone fluid (ii), at least one particulate metal oxide (iii) and, optionally, at least one catalyst (iv) for catalyzing the condensation of siloxy groups, (2) the equilibration reaction product of mixture (1), and (3) mixture (1) in which at least a portion of particulate metal oxide (iii) is pre-hydrophobized; (d) optionally, at least one additional bioinert material; and, (e) water.
    Type: Grant
    Filed: May 9, 2011
    Date of Patent: October 8, 2013
    Assignee: Momentive Performance Materials Inc.
    Inventors: William L Brown, Kalman Koczo, George A Policello
  • Patent number: 8517736
    Abstract: The present invention relates to a method for reducing or eliminating loss of minerals from the enamel and dental hypersensitivity against temperature changes, in particular when caused by the bleaching of teeth with products containing hydrogen peroxide or other oxidizing agents. After the bleaching process the teeth are treated with a calcium hydroxide containing solution, and subsequently the teeth are treated with a fluoride solution.
    Type: Grant
    Filed: January 10, 2012
    Date of Patent: August 27, 2013
    Assignee: Dr. Gunnar Rolla Consultant AS
    Inventor: Gunnar Rolla
  • Publication number: 20130122057
    Abstract: Cements containing certain small molecule amino acid phosphate compounds such as phosphoserine and certain multivalent metal compounds such as but not limited to calcium phosphate have been found to have improved properties and form a macromolecular network in the presence of a bioactive glass material that contain silicates, phosphates, and calcium salts which can be involved in the formation of bonding sites.
    Type: Application
    Filed: November 9, 2012
    Publication date: May 16, 2013
    Inventors: Venkat R. Garigapati, Matthew E. Murphy, Cassandra L. Kimsey
  • Patent number: 8404263
    Abstract: The resent invention relates to an agrochemical formulation comprising a pesticide, an organic UV photoprotective filter and coated metal oxide nanoparticles. It also relates to a method for preparing said formulation. Further on, it also relates to the use of a mixture of an organic UV photoprotective filter and coated metal oxide nanoparticles in agrochemical formulations and the use of a agrochemical formulation according to the invention for stabilizing a pesticide against UV irradiation.
    Type: Grant
    Filed: June 15, 2009
    Date of Patent: March 26, 2013
    Assignee: BASF SE
    Inventors: Michael Ishaque, Gerhard Schnabel, Douglas D. Anspaugh
  • Patent number: 8404262
    Abstract: The present invention relates to improved compositions for controlling marine pest anemones, to methods of application of same, and to kits for the convenient dispensing of such compositions.
    Type: Grant
    Filed: December 31, 2008
    Date of Patent: March 26, 2013
    Assignee: Red Sea Fish Pharm Ltd.
    Inventor: Sharon Ram
  • Patent number: 8372293
    Abstract: The invention concerns a process for the preparation of aqueous suspensions of fluid mineral matter, which are able to be pumped and conveyed by the end user immediately after the filtration stage, possibly followed by a compression, which process comprises filtration in two separate stages. The invention also concerns aqueous suspensions of mineral matter obtained and their uses.
    Type: Grant
    Filed: July 16, 2003
    Date of Patent: February 12, 2013
    Assignee: Omya Development AG
    Inventors: Maurice Husson, Christian Jacquemet, Eugène Vorobiev
  • Patent number: 8337904
    Abstract: A stable, phase-pure magnesium-substituted crystalline hydroxyapatite containing from about 2.0 to about 29 wt % magnesium, wherein at least 75 wt % of the magnesium content is substituted for calcium ions in the hydroxyapatite lattice structure.
    Type: Grant
    Filed: April 27, 2010
    Date of Patent: December 25, 2012
    Assignees: Rutgers, The State University of New Jersey, Ethicon, Inc.
    Inventors: Richard E. Riman, Wojciech Suchanek, Pavel Shuk, Kevor S. TenHuisen, Chun-Wei Chen
  • Patent number: 8328917
    Abstract: The present invention relates to an air filtration system and a method for making a photocatalytic oxidation substrate by powder coating a photocatalyst onto a metal substrate.
    Type: Grant
    Filed: October 22, 2010
    Date of Patent: December 11, 2012
    Assignee: Garfield Industries, Inc.
    Inventors: Kirk Garfield, John Potter
  • Publication number: 20120301529
    Abstract: The present invention refers to the use of a powder of vitreous composition, characterised in that it has a minimum CaO content of 10% by weight, as biocide
    Type: Application
    Filed: December 7, 2010
    Publication date: November 29, 2012
    Applicant: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
    Inventors: Jose Moya Corral, Leticia Esteban, Carlos Pecharroman, Francisco Malpartida
  • Patent number: 8298588
    Abstract: An improved dietary and/or therapeutic supplement composition comprising a quantity of a dietary and/or therapeutic supplement agent having a pH that upon ingestion with food or a beverage would limit the effectiveness of the agent and a sufficient amount of an alkaline electrolyte additive is provided in combination with the agent to raise the pH of the composition to a level of from about 8 to about 12.5 to increase the effectiveness and functional utilization of the agent while the composition is in the person's stomach. The supplement composition is designed to provide for optimum utilization of a dietary and/or therapeutic supplement agent when taken orally with food or a beverage.
    Type: Grant
    Filed: April 11, 2008
    Date of Patent: October 30, 2012
    Inventors: Janmarie Hornack, Lawrence E. Dorman
  • Publication number: 20120251450
    Abstract: Of the many compositions and methods provided herein, one composition includes a nanoparticle having a first oxide of a first metal and a dopant that includes an ion or an atom of a second metal. A method includes a method comprising providing a plurality of nanoparticles comprising a first oxide of a first metal and a dopant that comprises an ion or an atom of a second metal; providing a diseased cell and a healthy cell; contacting the diseased cell and the healthy cell with the nanoparticle; and allowing the nanoparticle to preferentially associate with the diseased cell.
    Type: Application
    Filed: April 4, 2011
    Publication date: October 4, 2012
    Inventors: Alex Punnoose, Denise Wingett
  • Publication number: 20120219635
    Abstract: A bioactive tissue scaffold is fabricated from glass fiber that forms a rigid three-dimensional porous matrix having a bioactive composition. Porosity in the form of interconnected pore space is provided by the pore space between the glass fiber in the porous matrix. Mechanical properties such as strength, elastic modulus, and pore size distribution is provided by the three-dimensional matrix that is formed by bonded overlapping and intertangled fibers. The bioactive tissue scaffold can be formed from raw materials that are not bioactive, but rather precursors to bioactive materials. The bioactive tissue scaffold supports tissue in-growth to provide osteoconductivity as a resorbable tissue scaffold, used for the repair of damaged and/or diseased bone tissue.
    Type: Application
    Filed: May 3, 2011
    Publication date: August 30, 2012
    Applicant: BIO2 TECHNOLOGIES, INC.
    Inventor: James Jenq Liu
  • Publication number: 20120148646
    Abstract: Nanoparticulate material containing a matrix and embedded therein a radiopacifier are bioactive, show a high alkaline capacity and are radio-opaque. Compositions and formulations including such material are particularly useful in advanced dental applications, such as dental fillings and/or disinfection.
    Type: Application
    Filed: August 17, 2010
    Publication date: June 14, 2012
    Applicants: UNIVERSITAT ZURICH, ETH ZURICH
    Inventors: Wendelin Jan Stark, Dirk Mohn, Matthias Zehnder, Thomas Imfeld
  • Publication number: 20120128748
    Abstract: Organic-inorganic composite particles includes inorganic oxide particles each of which has a cationic charge on the particle surface and polymer gel molecules which are derived from a natural substance, have an anionic functional group and one or more hydroxyl groups in a molecule and have both a shrinking and a swelling property, the polymer gel molecules are electrostatically bonded to surfaces of the inorganic oxide particles; a process for producing the particles; a dispersion containing the particles; and a cosmetic containing the particles. These organic-inorganic composite particles have good dispersibility not only in aqueous solvents such as water but also in non-aqueous solvents and further have characteristics that aggregation of the particles scarcely occurs.
    Type: Application
    Filed: July 30, 2010
    Publication date: May 24, 2012
    Applicant: JGC CATALYSTS AND CHEMICALS LTD.
    Inventors: Kensuke Nagata, Michio Komatsu
  • Publication number: 20120009280
    Abstract: A method of producing an animal feed product from a wet biological material, having a physical form selected from solutions, suspensions, emulsions, gums, mousses, sludges, slurries, and particulate materials, includes the step of combining the biological material with a base comprising a metal oxide in an amount which is sufficient to heat the biological material to a temperature of above 50° C. by reaction of water in the biological material with the metal oxide to produce the animal feed product. The product has a physical form which is easier to handle than that of the wet biological material and is selected from particulate materials and, granular materials. The base is preferably calcium oxide.
    Type: Application
    Filed: March 12, 2010
    Publication date: January 12, 2012
    Applicant: Bio-Energy Ingredients Limited
    Inventors: Richard Alwyn Houseman, Abraham Christo Venter
  • Publication number: 20110274769
    Abstract: An antibacterial melamine product includes a main body that is formed by heating and filling molding to have a predetermined shape. The main body includes a substrate portion and an antibacterial agent mixed with the substrate portion. The substrate portion is made of melamine formaldehyde. The antibacterial agent is fused in the substrate portion evenly. Thus, the antibacterial agent is mixed with the substrate portion to form the main body so that the main body of the antibacterial melamine product has different antibacterial effects by the antibacterial features provided by the antibacterial agent.
    Type: Application
    Filed: May 4, 2010
    Publication date: November 10, 2011
    Inventor: Xing-Yi Chen
  • Patent number: 8038935
    Abstract: Methods of removing odors, particularly odors within enclosed environments are provided which employ nanocrystalline metal oxide and metal hydroxide particles. The nanocrystalline particles are dispersed within an enclosed space so as to contact exposed surfaces located within the space such as walls, floors, upholstery, and the like and adsorb odor-causing materials located within the enclosed space.
    Type: Grant
    Filed: October 26, 2006
    Date of Patent: October 18, 2011
    Assignee: NanoScale Corporation
    Inventors: Olga Koper, HaiDoo Kwen, Scott Toerber, Kyle Knappenberger, David Jones, Debbie Basco, Ken Klabunde, Bill Sanford
  • Publication number: 20110217390
    Abstract: A method of manufacturing digestible powder that generates a hydride ion (H?) when dissolved in water is provided. A vacuum oven system that can reach 600° C. and 10?5 torr is used within this method. The method according to this current application comprises of ten to eleven steps of vacuuming, heating and hydrogen treatment of coral reef powder. By adding mixtures of magnesium, phosphorus and potassium, the maximum treating temperature and vacuum pressure is lowered. The coral reef powders treated via the ten steps emit hydrogen when dissolved in the water like powders that are treated with a mixture of natural form of magnesium, phosphorus and potassium complex. Those natural form of the magnesium, phosphorous and potassium includes (NH4)MgPO4.6H2O (struvite), MgSO4.KCl.H2O (Kainite), K2SO4.MgSO4.6H2O (Schonite), K2SO4.MgSO4.4H2O (Leonite), and K2SO4.2MgSO4 (Langbeinite).
    Type: Application
    Filed: March 3, 2010
    Publication date: September 8, 2011
    Inventor: Tetsunori Kunimune
  • Publication number: 20110117070
    Abstract: Compositions and methods for the treatment of headaches, such as migraine and cluster headaches, comprising co-administration of a first therapeutic component comprising topiramate and a second therapeutic component comprising a therapeutically effective amount or mixture of one or more therapeutic agents selected from the group consisting of riboflavin, magnesium, coenzyme Q10, petasin, isopetasin, and parthenolide. Also disclosed are methods for increasing the efficacy, and reducing or preventing side effects, of topiramate treatment.
    Type: Application
    Filed: July 27, 2010
    Publication date: May 19, 2011
    Inventors: Sheena K. Aurora, Curt Hendrix
  • Publication number: 20110097366
    Abstract: Goniochromatic/light reflecting cosmetic compositions well suited for making up the skin, lips, hair or integuments, contain (a) at least one goniochromatic coloring agent and (b) an amount of light reflective particles different from said at least one goniochromatic coloring agent and selected from the group consisting of (i) particles of a natural or synthetic substrate at least partially coated with at least one layer of at least one metal, (ii) particles of a synthetic substrate at least partially coated with at least one layer of at least one metallic compound, (iii) particles which comprise a stack of at least two layers of materials having different refractive indices, at least one of such layers optionally comprising a polymer, and (iv) metal oxide particles, formulated into (c) a topically applicable, physiologically acceptable medium therefor.
    Type: Application
    Filed: July 30, 2010
    Publication date: April 28, 2011
    Applicant: Societe L'Oreal, S.A.
    Inventors: Jean-Christophe Simon, Franck Girier-Dufournier, Patricia Lemann
  • Patent number: 7884089
    Abstract: An antimicrobial coating composition consisting essentially of 70 to 80 wt. percent water; 5 to 10 wt. percent methyl alcohol; 3 to 8 wt. percent octadecyl dimethyl trimethoxy silylpropyl-ammonium chloride; 1 to 5 wt. percent chloropropyl trimethoxysilane; 0.5 to 1.5 wt. percent aminopropyltrialkoxysilane; 0.5 to 1.5 wt. percent of a surfactant; 1 to 1.5 wt. percent of an anti-microbial agent; and 0.5 to 2.5 wt. percent sulfuric acid.
    Type: Grant
    Filed: February 6, 2009
    Date of Patent: February 8, 2011
    Assignee: Xurex, Inc.
    Inventor: Bo H. Gimvang
  • Publication number: 20110021355
    Abstract: The invention relates to formulations of hygroscopic solids with a lipophilic coating layer, and a method of production thereof.
    Type: Application
    Filed: April 11, 2009
    Publication date: January 27, 2011
    Applicant: BAYER TECHNOLOGY SERVICES GMBH
    Inventors: Jesko Zank, Martin Steinbeck, Guido Becker, Udo Van Stiphout
  • Publication number: 20100260866
    Abstract: Modified mineral-based fillers with enhanced retention of at least one active ingredient and/or enhanced antimicrobial capabilities are described. The materials comprise at least one mineral-based filler subjected to at least one modification process, which may be either a cationic modification process, a surface adsorption process, a surface retention process, or a combination thereof, with at least one active ingredient, followed by at least one thermal treatment. The at least one active ingredient may be a metal substance or other biocide, fungicide, mildewcide, antibiotic, insecticide, preservative, or antimicrobial agent. Methods for enhancing the antimicrobial activity of products in applications such as polymers, clothing, surgical equipment, coatings, and paints are also described.
    Type: Application
    Filed: October 27, 2008
    Publication date: October 14, 2010
    Applicant: World Minerals, Inc.
    Inventor: Jie Lu
  • Publication number: 20100247453
    Abstract: A composition comprising an antacid, and a local, topical anesthetic. The composition is used to relieve pain or discomfort associated with a sore throat, and therefore, the invention is also directed to a method of alleviating the pain or discomfort associated with a sore throat comprising instructing a human to orally administer the composition.
    Type: Application
    Filed: May 12, 2010
    Publication date: September 30, 2010
    Inventor: Thomas L. Jones
  • Publication number: 20100227006
    Abstract: A composition comprising a powder mixture of potassium citrate and calcium citrate as mixtures of pure chemical salts and methods of making and using the composition are disclosed. The composition is useful for the treatment and prevention of kidney stones and osteoporosis and better delivers potassium and calcium than commonly used potassium and calcium supplements.
    Type: Application
    Filed: May 20, 2010
    Publication date: September 9, 2010
    Applicants: MISSION PHARMACAL CO., THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Charles Y. C. Pak, Khashayar Sakhaee, Neill B. Walsdorf, SR.
  • Patent number: 7754234
    Abstract: A composition comprising an antacid, and a local, topical anesthetic. The composition is used to relieve pain or discomfort associated with a sore throat, and therefore, the invention is also directed to a method of alleviating the pain or discomfort associated with a sore throat comprising instructing a human to orally administer the composition.
    Type: Grant
    Filed: July 12, 2006
    Date of Patent: July 13, 2010
    Inventor: Thomas L. Jones
  • Publication number: 20100143502
    Abstract: A plant wash comprising a mixture of dormant oil and hop extract in a carrier is useful for protecting fruit trees against freeze damage, bacterium, pest infestations, fungi and wilt.
    Type: Application
    Filed: November 23, 2009
    Publication date: June 10, 2010
    Inventor: Roger Rolland Ellis
  • Publication number: 20100136131
    Abstract: The present invention provides a composite material comprising fibrinogen or fibrin, or a mixture thereof, and a bioactive glass. The invention also relates to wound dressings and pharmaceutical compositions containing the composite material. Further aspects of the invention relate to the use of the composite material of the for treating a wound, treating or preventing bacterial infections in a wound, preventing or alleviating bleeding in a wound, sterilising a wound, controlling haemorrhaging, increasing the rate of coagulation of blood and/or activating a coagulation system in a wound.
    Type: Application
    Filed: August 21, 2007
    Publication date: June 3, 2010
    Applicants: NOVATHERMA LIMITED, PHARMING GROUP NV
    Inventors: Gareth Roberts, Robert Daniels, Xiaobin Zhao, Ian Thompson
  • Patent number: 7700133
    Abstract: Formulations and blends are described comprising zinc, silver, bismuth and copper in non-toxic amounts that are useful as treatments of a wide variety of conditions and diseases promoted by bacteria or other microorganisms.
    Type: Grant
    Filed: February 17, 2005
    Date of Patent: April 20, 2010
    Inventors: Marianna Cooley, Timothy W. Fraser
  • Publication number: 20100040655
    Abstract: The present invention provides the use of nanoparticles of a compound of general formula MnXy, where M is (i) a metal selected from the group consisting of Calcium (Ca), Aluminium (Al), Zinc (Zn), Nickel (Ni), Tungsten (W) or Copper (Cu); or (ii) a non-metal selected from the group consisting of Silicon (Si), Boron (B) or Carbon (C); in which n is equal to 1, 2, or 3, and X is (iii) a non-metal selected from the group consisting of Oxygen (O), Nitrogen (N), or Carbon (C); or (iv) an anion selected from the group consisting of phosphate (PO43?), hydrogen phosphate (HPO42?), dihydrogen phosphate (H2PO4?), carbonate (CO3), silicate (SiO42?), sulphate (SO42?), nitrate (NO3?), nitrite (NO2?); in which y is equal to 0, 1, 2, 3 or 4; for use in reducing and/or preventing virus transmission. Articles of protective clothing or filters are provided in which the fibres are coated with said nanoparticles for use in reducing and/or preventing virus transmission.
    Type: Application
    Filed: February 16, 2007
    Publication date: February 18, 2010
    Applicants: QUEEN MARY & WESTFIELD COLLEGE, INTRINSIQ MATERIALS LIMITED, RETROSCREEN VIROLOGY LIMITED
    Inventors: Guogang Ren, John Sidney Oxford, Paul William Reip, Robert Lambkin-Williams, Alexander Mann
  • Patent number: 7638506
    Abstract: Provided is a granular agrochemical composition by which the problems accompanying the prior art granular agrochemical compositions can be overcome, which can be prepared in a simple formulation and by which sustained releasability of the agrochemically active ingredient is obtained so that the load on the environments can be decreased and the chemical damages caused by the agrochemically active ingredient can be alleviated or prevented. The granular agrochemical composition contains an acidic agrochemically active ingredient, a cationic surfactant and a basic substance. Inter alia, a pH of 5 or higher is obtained in a 1% by mass aqueous suspension thereof. Preferably, the acidic agrochemically active ingredient should have a pKa of 2 to 7 and the cationic surfactant should be one which is gelled or exhibits swellability in water.
    Type: Grant
    Filed: December 27, 2006
    Date of Patent: December 29, 2009
    Assignee: Kumiai Chemical Industry Co., Ltd.
    Inventors: Eisuke Ozaki, Kazunori Kurita, Tetsuo Ohkawa